Shaikha Alqahtani MD (@shaikhaq14) 's Twitter Profile
Shaikha Alqahtani MD

@shaikhaq14

PTCT Fellow@duke 2024. Chief PHO fellow @mdandersonnews 2023/24. Peds resident @vcupeds 2021@WCMqatar. class of 2018 MedEd/research. Views are my own.

ID: 1347395306640584704

calendar_today08-01-2021 04:10:55

339 Tweet

299 Takipçi

360 Takip Edilen

Carmem Bonfim (@carmembonfim1) 's Twitter Profile Photo

Duke Children's Dr Joanne Kurtzberg Shaikha Alqahtani MD Dr Fabiana Cacace Duke Hematologic Malignancies & Cellular Therapy Dr Keith Sullivan & Dr Nelson Chao ( ASTCT 6th international symposium & ASTCT international council ). Some of the amazing work presented by Duke university at #Tandem25 meeting! 🔝🔝❤️❤️Kris Mahadeo

<a href="/Duke_Childrens/">Duke Children's</a> Dr Joanne Kurtzberg <a href="/ShaikhaQ14/">Shaikha Alqahtani MD</a> Dr Fabiana Cacace <a href="/DukeHMCT/">Duke Hematologic Malignancies & Cellular Therapy</a> Dr Keith Sullivan &amp; Dr Nelson Chao ( <a href="/ASTCT/">ASTCT</a> 6th international symposium &amp; <a href="/ASTCT/">ASTCT</a> international council ). Some of the amazing work presented by Duke university at  #Tandem25 meeting! 🔝🔝❤️❤️<a href="/MahadeoKris/">Kris Mahadeo</a>
Kris Mahadeo (@mahadeokris) 's Twitter Profile Photo

Dr. William Owen Children's Hospital of The King's Daughters (CHKD) will lead a discussion Duke Children's PTCT Seminar tommorow on Considerations for Gene Therapy versus HCT in #sicklecelldisease. duke.zoom.us/webinar/regist…. 2pm EST on Friday February 21st.

Transplantation and Cellular Therapy Journal (@astct_journal) 's Twitter Profile Photo

This study introduces a scoring system to guide risk-adapted letermovir use after #alloHCT, effectively preventing long-term cytomegalovirus infection in high-risk patients while reducing overall drug use. Read the full study: ow.ly/YNfe50VrFyK

This study introduces a scoring system to guide risk-adapted letermovir use after #alloHCT, effectively preventing long-term cytomegalovirus infection in high-risk patients while reducing overall drug use. Read the full study: ow.ly/YNfe50VrFyK
American Society of Pediatric Hematology/Oncology (@aspho_hq) 's Twitter Profile Photo

Watch a video message from #EmilyRav, DO, of Cook Children's, to get a sneak preview of the #ASPHO2025 session she will be moderating, "Physical Activity Guidelines for Children with Cancer - Time to Make a Move." Join the #PedsHemeOnc #PHODocs community at #ASPHO2025!

ASTCT (@astct) 's Twitter Profile Photo

Join the Cord Blood SIG on May 7 for an overview of recent developments in cord blood transplant for heme malignancies. The focus of this webinar will be on manipulated graft sources and insights from real world use of expanded cord blood. Register now: ow.ly/Fmn350VF2bG

Join the Cord Blood SIG on May 7 for an overview of recent developments in cord blood transplant for heme malignancies. The focus of this webinar will be on manipulated graft sources and insights from real world use of expanded cord blood. Register now: ow.ly/Fmn350VF2bG
Transplantation and Cellular Therapy Journal (@astct_journal) 's Twitter Profile Photo

New research highlights how age, conditioning intensity and acute #GVHD impact thymic recovery after #alloHCT in children with inborn errors of immunity. Measuring recent thymic emigrants may guide personalized strategies to improve outcomes. Read more: ow.ly/cNrN50VNaGT

New research highlights how age, conditioning intensity and acute #GVHD impact thymic recovery after #alloHCT in children with inborn errors of immunity. Measuring recent thymic emigrants may guide personalized strategies to improve outcomes. Read more: ow.ly/cNrN50VNaGT
Transplantation and Cellular Therapy Journal (@astct_journal) 's Twitter Profile Photo

A new study shows influenza-specific T-cell responses can be induced before #CART therapy, even without antibody response, and may persist after infusion. Findings support vaccination at least two weeks before lymphodepletion. Read more: astctjournal.org/article/S2666-…

A new study shows influenza-specific T-cell responses can be induced before #CART therapy, even without antibody response, and may persist after infusion. Findings support vaccination at least two weeks before lymphodepletion. Read more: astctjournal.org/article/S2666-…
The EBMT (@theebmt) 's Twitter Profile Photo

💡 Have you seen The EMJ Review of EBMT 2025? Get a comprehensive overview of the key highlights from #EBMT25, including 🗣️ expert interviews and 🔬 cutting-edge research updates on a Phase II therapeutic trial in Hodgkin lymphoma, clonal haematopoiesis following HCT in

💡 Have you seen The EMJ Review of EBMT 2025?

Get a comprehensive overview of the key highlights from #EBMT25, including 🗣️ expert interviews and 
🔬 cutting-edge research updates on a Phase II therapeutic trial in Hodgkin lymphoma, clonal haematopoiesis following HCT in
NEJM (@nejm) 's Twitter Profile Photo

Presented at #EHA2025: Among patients undergoing stem-cell transplantation from matched related donors, cyclophosphamide plus cyclosporin led to significantly longer GVHD-free, relapse-free survival than standard prophylaxis. Full ALLG BM12 CAST phase 3 trial results:

Presented at #EHA2025:

Among patients undergoing stem-cell transplantation from matched related donors, cyclophosphamide plus cyclosporin led to significantly longer GVHD-free, relapse-free survival than standard prophylaxis. Full ALLG BM12 CAST phase 3 trial results:
Carmem Bonfim (@carmembonfim1) 's Twitter Profile Photo

Let’s learn more about Vitamin A & GVHD? Come & join us today at 2 pm EST. Duke Children's PTCT seminars Kris Mahadeo will have Dr Stella Davies Cincinnati Children's talking about this🔝topic. Vitamin A is accessible worldwide! Register here: duke.zoom.us/webinar/regist… SBTMO LABMT